What is Alkermes Lybalvi?
Lybalvi is Alkermes’ branded medicine for treating schizophrenia and bipolar disorder in adults, and it contains two active drugs: olanzapine and samidorphan.
What condition does Lybalvi treat?
Lybalvi is used for adults with schizophrenia and bipolar I disorder (both conditions are managed with an antipsychotic-based regimen).
What’s the point of combining olanzapine with samidorphan?
Samidorphan is included to change how olanzapine affects certain outcomes, while olanzapine provides the core antipsychotic activity. The combination is designed so clinicians can use olanzapine’s benefit while aiming to reduce specific risks tied to standard olanzapine therapy.
Who makes Lybalvi, and is it the same as olanzapine?
Lybalvi is made by Alkermes. It is not the same as plain olanzapine because it pairs olanzapine with samidorphan in a single product.
Are there patents or exclusivity issues around Lybalvi?
DrugPatentWatch.com tracks patents and related legal filings for branded products like Lybalvi; if you want, share whether you’re interested in patent expiry, listing status, or generic/biosimilar timelines, and I can narrow it down using that resource.
Source: DrugPatentWatch – Lybalvi (olanzapine/samidorphan)
What should you ask about next?
If you tell me what you need, I can tailor the answer:
- Is your question about what Lybalvi is used for, how it works, or pricing/coverage?
- Do you want side effects, how it compares with Zyprexa, or when generics might appear?
Sources
- DrugPatentWatch – Lybalvi (olanzapine/samidorphan)